Pharma Worried Over Implementation of EMA's Traceability Requirements For Biologicals
Executive Summary
EU pharmaceutical companies believe that batch traceability and product identification requirements in the European Medicines Agency's recently-finalized guideline on pharmacovigilance of biological medicines does not take into account the realities and practicalities of marketing such products.